PhilipWaltonLairdMD

Retinal Disease

Practices at Retina Care Specialists in Palm Beach Gardens, Stuart, and Port St. Lucie, Florida. Practice website is: www.retinacarespecialists.com

Join to view full profile

Dr. Laird is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Laird's full profile

Already have an account?

Office
3399 Pga Blvd
Ste 350
North Palm Beach, FL 33410
Phone+1 561-624-0099

Fax+1 561-624-7373
Is this information wrong?

Summary

Philip Laird M.D. is a native Floridian who graduated with Honors from University of Florida. While at Florida, he was a member of the varsity Track & Field and Cross Country teams. He is a recipient of the College of Health and Human Performance Outstanding Young Alumnus Award.

Dr. Laird then attended medical school at Mayo Clinic in Rochester, Minnesota and was awarded the Dean's Award as well as a National Eye Institute research award. He then completed a General Surgery internship at the Mayo Clinic in Jacksonville, Florida.

Dr. Laird attained his formal Ophthalmology training at Emory University in Atlanta, Georgia. After completing residency, he stayed at Emory for a two-year fellowship in Vitreoretinal Disease and Surgery.

Dr. Laird has published numerous manuscripts and book chapters in the field of Ophthalmology and Retina and has presented his research at national forums. He is an investigator in multiple clinical trials and currently serves as a reviewer for the American Journal of Ophthalmology.

Dr. Laird is a Board-Certified Ophthalmologist specializing in all aspects of Vitreoretinal disease and surgery. He is an active member of the American Society of Retina Specialists and the American Academy of Ophthalmology.

Outside of medicine, Dr. Laird lives in Jupiter and is happily married with two children. He enjoys distance running, traveling, and spending time with his family.

Education & Training

Emory University School of MedicineFellowship, Surgical Retina and Vitreous, 2012 - 2014
Emory University School of MedicineResidency, Ophthalmology, 2009 - 2012
Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2008 - 2009
Mayo Clinic College of MedicineClass of 2008

Certifications & Licensure

FL State Medical License 2014 - 2026
GA State Medical License 2011 - 2014
American Board of Ophthalmology Ophthalmology

Clinical Trials

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy Start of enrollment: 2013 Aug 01
Terminated
Phase 3
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Start of enrollment: 2014 Sep 18
Terminated
Phase 3
An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy Start of enrollment: 2012 May 29
Terminated
Phase 2
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1 Start of enrollment: 2014 Dec 08
Completed
Phase 3
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) Start of enrollment: 2016 Jul 21
Terminated
Phase 3
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) Start of enrollment: 2015 Aug 11
Completed
Phase 2
A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration Start of enrollment: 2015 Jun 25
Completed
Phase 3
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE) Start of enrollment: 2019 Mar 11
Completed
Phase 3
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration Start of enrollment: 2021 Apr 19
Active, not recruiting
Phase 3
A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration Start of enrollment: 2020 Jul 30
Terminated
Phase 2
A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration Start of enrollment: 2018 Sep 12
Completed
Phase 3
Extension Study for the Port Delivery System With Ranibizumab (Portal) Start of enrollment: 2018 Sep 20
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) Start of enrollment: 2018 Sep 05
Completed
Phase 3
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema Start of enrollment: 2020 Aug 05
Completed
Phase 3
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) Start of enrollment: 2020 Jun 22
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

3 citations
Toxoplasmosis chorioretinitis mimicking acute retinal necrosis associated with local corticosteroid
Jason N. Crosson, Sanjana Kuthyar, Jessica G. Shantha, Matthew R. Debiec, Philip W. Laird, Cindy S. Hwang, Hans E. Grossniklaus, Steven Yeh> ;International Journal of Retina and Vitreous. 2020 Jun 3
5 citations
Formulation of a Peribulbar Block for Prolonged Postoperative Pain Management in Vitreoretinal Surgery: A Randomized Clinical Trial
Sonia Mehta, Philip W. Laird, Matthew R. Debiec, Cindy S. Hwang, Rui Zhang, Jiong Yan, Andrew Hendrick, G. Baker Hubbard, Chris S. Bergstrom, Steven Yeh, Alcides Ferna...> ;Ophthalmology. Retina. 2017 Sep 1
65 citations
Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma.
Jason N. Crosson, Philip W. Laird, Matthew R. Debiec, Chris S. Bergstrom, David H. Lawson, Steven Yeh> ;Journal of Immunotherapy. 2015 Feb 1
6 citations
Toxoplasma chorioretinitis diagnosed by histopathology in a patient with AIDS.
Jason N. Crosson, Philip W. Laird, Hans E. Grossniklaus, Andrew Hendrick> ;Retinal Cases & Brief Reports. 2015 Jan 1
8 citations
Ciliary body medulloepithelioma associated with pleuropulmonary blastoma.
Philip W. Laird, Hans E. Grossniklaus, G. Baker Hubbard> ;The British Journal of Ophthalmology. 2013 Aug 1
1 citations
August 2012 Cover Photo Is Not Coats' Disease
Philip W. Laird, G. Baker Hubbard> ;Ophthalmology. 2013 Jul 1
3 citations
Cystic benign melanosis of the conjunctiva.
Philip W. Laird, Maria A. Woodward, John G. Williams, W. Barry Lee, Hans E. Grossniklaus> ;Cornea. 2012 Nov 1
23 citations
Exacerbation of Susac syndrome retinopathy by interferon Beta-1a.
Philip W. Laird, Nancy J. Newman, Steven Yeh> ;Archives of Ophthalmology. 2012 Jun 1
Distance stereoacuity in prism-induced convergence stress.
Alison Y. Firth, Helen Davis> ;Journal of AAPOS. 2008 Aug 1
14 citations
Distance stereoacuity in prism-induced convergence stress
Philip W. Laird, Sarah R. Hatt, David A. Leske, Jonathan M. Holmes> ;Journal of AAPOS. 2008 Aug 1
20 citations
Stereoacuity and binocular visual acuity in prism-induced exodeviation.
Philip W. Laird, Sarah R. Hatt, David A. Leske, Jonathan M. Holmes> ;Journal of AAPOS. 2007 Aug 1
6 citations
Bull's-Eye Maculopathy in an Infant With Leigh Disease
Philip W. Laird, Brian G. Mohney, Deborah L. Renaud> ;American Journal of Ophthalmology. 2006 Jul 1
Join now to see all